Outsourced partners can help innovators make better decisions earlier in development, before uncertainty becomes late-stage risk.
Katie Edgar
Advertisement
Katie Edgar is chief business officer at KBI Biopharma.
Articles by Katie Edgar
Advertisement
Latest Updated Articles
Reshaping Outsourced Development and ManufacturingFebruary 27th 2026
Advertisement
Advertisement
Trending on BioPharm International
1
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
2
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
3
Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Berobenatide Development
4
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
5